Long-term efficacy of rimonabant in improving glucose tolerance in overweight/obese non-diabetic patients: 2-year results from RIO-Europe

被引：0
作者：
Scheen, Andre J.
Van Gaal, Luc
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A31 / A31
页数：1
相关论文
共 50 条
[31]   MRI Outcomes from the Long-term Extension Study of Tolebrutinib in Patients with Relapsing Multiple Sclerosis: 2-Year Results [J].
Reich, Daniel ;
Traboulsee, Anthony ;
Syed, Sana ;
Xu, Zhixing ;
Turner, Timothy ;
Arnold, Douglas .
NEUROLOGY, 2023, 100 (17)
[32]   Long-term safety and efficacy of risperidone in children with disruptive behaviour disorders - Results of a 2-year extension study [J].
Reyes, M ;
Olah, R ;
Csaba, K ;
Augustyns, I ;
Eerdekens, M .
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2006, 15 (02) :97-104
[33]   LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 1 STUDY [J].
Mcinnes, I. ;
Kato, K. ;
Magrey, M. ;
Merola, J. F. ;
Kishimoto, M. ;
Haaland, D. ;
Chen, L. ;
Duan, Y. ;
Liu, J. ;
Lippe, R. ;
Wung, P. .
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 :260-261
[34]   MRI outcomes from the long-term extension study of tolebrutinib in patients with relapsing multiple sclerosis: 2-year results [J].
Reich, D. S. ;
Traboulsee, A. ;
Syed, S. ;
Xu, Z. ;
Turner, T. J. ;
Arnold, D. L. .
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) :334-335
[35]   THE LONG-TERM EFFICACY AND SAFETY OF LOW-PROTEIN DIETS IN NON-DIABETIC PATIENTS WITH ADVANCED CKD: FOCUS ON ELDERLY [J].
Garneata, Liliana ;
Mocanu, Carmen-Antonia ;
Mircescu, Gabriel .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 :I426-I426
[36]   The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study [J].
J. Koska ;
E. Ortega ;
J. C. Bunt ;
A. Gasser ;
J. Impson ;
R. L. Hanson ;
J. Forbes ;
B. de Courten ;
J. Krakoff .
Diabetologia, 2009, 52
[37]   The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study [J].
Koska, J. ;
Ortega, E. ;
Bunt, J. C. ;
Gasser, A. ;
Impson, J. ;
Hanson, R. L. ;
Forbes, J. ;
de Courten, B. ;
Krakoff, J. .
DIABETOLOGIA, 2009, 52 (03) :385-393
[38]   Long-term safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis type II: 2-year results from a phase 2/3 extension study [J].
Muenzer, Joseph ;
Burton, Barbara K. ;
Harmatz, Paul ;
Gonzalez Gutierrez-Solana, Luis ;
Ruiz-Garcia, Matilde ;
Jones, Simon A. ;
Guffon, Nathalie ;
Inbar-Feigenberg, Michal ;
Bratkovic, Drago ;
Li, Xiaoxi ;
Yee, Karen S. ;
Alexanderian, David .
MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) :S73-S74
[39]   Long-Term Efficacy of Intravitreal Aflibercept Injections for the Treatment of Non-Proliferative Diabetic Retinopathy among Subjects Completing the 2-Year PANORAMA Trial [J].
Al-khersan, Hasenin ;
Patel, Sagar ;
Staropoli, Patrick C. ;
Major, James C. ;
Cao, Jessica ;
Saroj, Namrata ;
Sadda, SriniVas R. ;
Ip, Michael S. ;
Niu, Xiaomeng ;
Moini, Hadi ;
Berliner, Alyson J. ;
Hu, Allen ;
Emanuelli, Andres ;
Wykoff, Charles Clifton .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
[40]   Long-term efficacy of safinamide as add-on to levodopa in Parkinson's disease fluctuating patients: results from a 2-year placebo-controlled trial [J].
Anand, R. ;
Hartman, R. ;
Lucini, V. ;
Forrest, E. ;
Giuliani, R. ;
Cattaneo, C. ;
Camattari, G. ;
McBride, M. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 :E276-E276
12345